Hypera Pharma Competitors and Similar CompaniesClear all

Hypera Pharma's competitors and similar companies include Bausch Health Americas, Patheon, Akums Drugs and Pharmaceuticals and Innovent Biologics.

	Hypera Pharma Hypera Pharma is a pharmaceutical company that provides medicines and food supplements.	Bausch Health Americas Bausch Health Americas (BHA) is a pharmaceutical preparation manufacturing company.	Patheon Patheon is a company that provides commercial manufacturing and pharmaceutical development services.	Akums Drugs and Pharmaceuticals Akums Drugs and Pharmaceuticals is a contract development and manufacturing organization (CDMO).	Innovent Biologics Innovent Biologics is a biopharmaceutical company that develops and manufactures drugs.
Founding Date	Founding Date 2001	Founding Date 1994	Founding Date 2014	Founding Date 2004	Founding Date 2011
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Private	Type Public
Tags	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma	Tags Healthcare drug development pharma	Tags Manufacturing & Industrial drug development pharma
Locations	Locations São Paulo, BR HQ	Locations Bridgewater, US HQ Laval, CA Steinbach, CA Envigado, CO La Estrella, CO Medellín, CO Ciudad De México, MX see more	Locations Mississauga, CA HQ	Locations Delhi, IN HQ Delhi, IN	Locations Suzhou, CN HQ
Employees	Employees 10,481	Employees 4,044	Employees 6,500	Employees 4,4829% increase	Employees 5,659
Financial
Revenue (est.)	Revenue (est.) R$7.7b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥13b (FY, 2025)
Cost of goods	Cost of goods R$2.8b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥1.1b (FY, 2025)
Gross profit	Gross profit R$4.9b (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥12b (FY, 2025)
Net income	Net income R$1.2b (FY, 2025)	Net income N/A	Net income N/A	Net income N/A	Net income ¥813.6m (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 150m	Total funding raised $ 70m	Total funding raised N/A